Melanoma of the Scalp Harboring a Novel AGFG1::ERBB4 Fusion: A Case Report With Clinicopathologic and Genomic Characterization.
7 affiliations
- 1Department of Pathology & Immunology, Baylor College of Medicine, Houston, Texas, USA.
- 2Department of Pathology and Laboratory Medicine, Ben Taub Hospital, Harris Health System, Houston, Texas, USA.
- 3School of Health Professions, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
- 4Department of Pathology and Laboratory Medicine, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, USA.
- 5Section of Infectious Diseases, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
- 6School of Medicine, Baylor College of Medicine, Houston, Texas, USA.
- 7Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
Abstract
ERBB4 (HER4) gain-of-function missense mutations have been implicated in cutaneous melanoma. In contrast, structural rearrangements involving ERBB4 are exceedingly rare. We describe a 59-year-old man with a rapidly enlarging 4.2-cm melanoma of the scalp with high-risk pathologic features, including epithelioid to plasmacytoid cytomorphology, ulceration, brisk mitotic activity, and microscopic satellitosis. RNA sequencing identified a novel in-frame AGFG1::ERBB4 fusion joining AGFG1 exon 2 to ERBB4 exon 2. The ERBB4 portion retains the downstream coding sequence, including the tyrosine kinase domain. Concurrent molecular alterations included a pathogenic NF1 loss-of-function alteration, a TERT promoter mutation, CDK4 and STAT6 copy-number gains, and TP53 copy-number loss in a BRAF/NRAS/KIT-wild-type background.
Related
- The Genomic Characterization of a Novel Candidatus Genus of the Family Gallionellaceae, a Novel Candidatus Species of the Genus Gallionella and Their Metabolic Potential for Iron Oxidation
- Molecular and genomic characterization of biofilm associated antimicrobial resistance in clinical and resistant isolates of Pseudomonas aeruginosa in Iraq
- Genomic and phenotypic characterization of a honey-derived Enterococcus faecium isolate from the Brazilian semiarid region
- Characterization and clustering of immunocompetent proteins based on ESM-2 sequence embedding and physicochemical feature fusion
- Cocoa Pulp Juice as a Fermentation Substrate for Potential Probiotic Lacticaseibacillus paracasei WU2502: Genomic Characterization, Metabolite Profiling, and Antimicrobial Activity Against Foodborne Pathogens
BibTeX
@article{cao2026melanoma,
title = {{Melanoma of the Scalp Harboring a Novel AGFG1::ERBB4 Fusion: A Case Report With Clinicopathologic and Genomic Characterization.}},
author = {Xu Cao and Hong Yu and Kenneth L Muldrew and Rachael M Johnson and Li Liang and Ying Pei and Yve T Huttenbach and C Cameron Yin and Songlin Zhang},
journal = {Genes, chromosomes \& cancer},
year = {2026},
month = oct,
doi = {10.1002/gcc.70183},
url = {https://europepmc.org/article/MED/42948860},
note = {CC BY},
}
RIS
TY - JOUR
TI - Melanoma of the Scalp Harboring a Novel AGFG1::ERBB4 Fusion: A Case Report With Clinicopathologic and Genomic Characterization.
AU - Xu Cao
AU - Hong Yu
AU - Kenneth L Muldrew
AU - Rachael M Johnson
AU - Li Liang
AU - Ying Pei
AU - Yve T Huttenbach
AU - C Cameron Yin
AU - Songlin Zhang
PY - 2026
DA - 2026/10/01
JO - Genes, chromosomes & cancer
DO - 10.1002/gcc.70183
UR - https://europepmc.org/article/MED/42948860
AB - ERBB4 (HER4) gain-of-function missense mutations have been implicated in cutaneous melanoma. In contrast, structural rearrangements involving ERBB4 are exceedingly rare. We describe a 59-year-old man with a rapidly enlarging 4.2-cm melanoma of the scalp with high-risk pathologic features, including epithelioid to plasmacytoid cytomorphology, ulceration, brisk mitotic activity, and microscopic satellitosis. RNA sequencing identified a novel in-frame AGFG1::ERBB4 fusion joining AGFG1 exon 2 to ERBB4 exon 2. The ERBB4 portion retains the downstream coding sequence, including the tyrosine kinase domain. Concurrent molecular alterations included a pathogenic NF1 loss-of-function alteration, a TERT promoter mutation, CDK4 and STAT6 copy-number gains, and TP53 copy-number loss in a BRAF/NRAS/KIT-wild-type background.
SN - 1045-2257
SN - 1098-2264
ER -